Maternal probiotic supplementation protects against PBDE-induced developmental, behavior and metabolic reprogramming in a sexually dimorphic manner: Role of gut microbiome
Archives of Toxicology · 2025
DOI: 10.1007/s00204-024-03882-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Toxicology, 2025. Verfasst von Maximillian E Denys und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Cell and Systems Biology, University of California, Riverside, CA, 92521, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Probiotics, Halogenated Diphenyl Ethers, Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Foundation for the National Institutes of Health, NIEHS NIH HHS.
Abstract (Originalsprache)
Polybrominated diphenyl ethers (PBDEs) are endocrine-disrupting persistent organic pollutants (POPs) used as flame retardants in a wide range of commercial applications. We have previously reported neurobehavioral and metabolic reprogramming produced by developmental PBDEs. PBDEs perturb the microbiome, an influencer of life-long health, while probiotic supplementation with Limosilactobacillus reuteri (LR) can avert neurobehavioral and endocrine disruption. We, therefore, tested the hypothesis that perinatal maternal LR supplementation would protect gut microbiome richness and diversity, developmental milestones, adult neurobehavior and metabolic homeostasis in PBDE-exposed offspring. C57BL/6N dams were orally exposed to a commercial penta-mixture of PBDEs, DE-71, at 0.1 mg/kg/day, or corn oil vehicle (VEH/CON) during gestation and lactation. Mice offspring received DE-71 or VEH/CON with or without co-administration of LR (ATCC-PTA-6475) indirectly via their mother from gestational day (GD) 0 until postnatal day (P)21 (Cohort 1), or continued to receive LR directly from P22 through adulthood (Cohort 2). Results of fecal 16S rRNA sequencing indicated age- and sex-dependent effects of DE-71 on gut microbial communities. Maternal LR treatment protected against DE-71-induced reduction in α-diversity in P22 females and against β-diversity alterations in P30 males. In females, DE-71 changed the relative abundance of specific bacterial taxa, such as Tenericutes and Cyanobacteria (elevated) and Deferribacterota (reduced). In males, several Firmicutes taxa were elevated, while Proteobacteria, Chlamydiae, and several Bacteroidota taxa were reduced. The number of disrupted taxa normalized by maternal LR supplementation was as follows: 100% in P22 females and 33% in males at P22 and 25% at P30. Maternal LR treatment protected against DE-71-induced delay of postnatal body weight gain in males and ameliorated the abnormal timing of incisor eruption in both sexes. Further, DE-71 produced exaggerated digging in both sexes as well as locomotor hyperactivity in females, effects that were mitigated by maternal LR only in females. Other benefits of LR therapy included normalization of glucose tolerance, insulin-to-glucose ratio and plasma leptin in adult DE-71 females (Cohort 2). This study provides evidence that probiotic supplementation can mitigate POP-induced reprogramming of neurodevelopment, adult neurobehavior, and glucose metabolism in association with modified gut microbial community structure in a sex-dependent manner.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Cell and Systems Biology, University of California, Riverside, CA, 92521, USA.
- Neuroscience Graduate Program, University of California, Riverside, CA, USA.
- Department of Microbiology and Plant Pathology, University of California, Riverside, CA, USA.
- Division of Biomedical Sciences, School of Medicine, University of California Riverside, Riverside, CA, USA.
- Department of Molecular Cell and Systems Biology, University of California, Riverside, CA, 92521, USA. mcur@ucr.edu.
ORCID-Profile: Maximillian E Denys, Elena V Kozlova, Anthony E Bishay, Elyza A Do, Varadh Piamthai, Crystal N Luna, Artha A Lam, Margarita Currás-Collazo
Förderung
- NIAID NIH HHS
- Foundation for the National Institutes of Health
- NIEHS NIH HHS
- NIGMS NIH HHS
Zitieren
APA
Denys, M. E., Kozlova, E. V., Liu, R., Bishay, A. E., Do, E. A., Piamthai, V., Korde, Y. V., Luna, C. N., Lam, A. A., Hsiao, A., & Currás-Collazo, M. (2025). Maternal probiotic supplementation protects against PBDE-induced developmental, behavior and metabolic reprogramming in a sexually dimorphic manner: Role of gut microbiome. Archives of Toxicology. https://doi.org/10.1007/s00204-024-03882-4
Vancouver
Denys ME, Kozlova EV, Liu R, Bishay AE, Do EA, Piamthai V, et al. Maternal probiotic supplementation protects against PBDE-induced developmental, behavior and metabolic reprogramming in a sexually dimorphic manner: Role of gut microbiome. Archives of Toxicology. 2025. doi:10.1007/s00204-024-03882-4
BibTeX
@article{Denys2025,
author = {Denys, Maximillian E and Kozlova, Elena V and Liu, Rui and Bishay, Anthony E and Do, Elyza A and Piamthai, Varadh and Korde, Yash V and Luna, Crystal N and Lam, Artha A and Hsiao, Ansel and Currás-Collazo, Margarita},
title = {Maternal probiotic supplementation protects against PBDE-induced developmental, behavior and metabolic reprogramming in a sexually dimorphic manner: Role of gut microbiome},
journal = {Archives of Toxicology},
year = {2025},
doi = {10.1007/s00204-024-03882-4}
}
EUVIMED